Literature DB >> 17420429

Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.

Joanne Thompson1, Marvin Reid, Ian Hambleton, Graham R Serjeant.   

Abstract

BACKGROUND: The glomerular filtration rate (GFR) in homozygous sickle cell (SS) disease is supranormal in childhood but falls steeply with age, often culminating in renal failure. The risk factors underlying these observations are unclear. We therefore sought to investigate the relationships between blood pressure, renal hemodynamics, and urinary albumin excretion in subjects with SS disease and matched controls with a normal AA genotype (hereinafter, controls) as a prelude to intervention studies.
METHODS: Serum creatinine level, GFR, effective renal plasma flow, blood pressure, and urinary albumin and creatinine excretion rates were measured in Jamaican individuals with SS disease aged 18 to 23 years and in controls followed from birth in a cohort study.
RESULTS: Compared with controls, subjects with SS disease showed lower blood pressure and normal or supranormal GFR and effective renal plasma flow. Urinary albumin excretion exceeded 20 microg/min in 26% of subjects with SS disease and correlated positively with GFR and systolic blood pressure and negatively with hematocrit. A higher GFR and increased tubular secretion of creatinine combined to lower serum creatinine levels in patients with SS disease, giving an upper limit of the reference range of 0.90 mg/dL (80 micromol/L) in men and 0.77 mg/dL (68 micromol/L) in women. In addition, creatinine clearance measurements were consistently greater than GFR in subjects with SS disease.
CONCLUSIONS: The GFR remained within reference range or elevated in patients with SS disease aged 18 to 23 years. The higher GFR in patients with albuminuria was consistent with the hypothesis that high glomerular flows cause renal damage. Lower serum creatinine levels characterize patients with SS disease, and a revised clinical definition based on serum creatinine level alone is proposed.

Entities:  

Mesh:

Year:  2007        PMID: 17420429     DOI: 10.1001/archinte.167.7.701

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  37 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

Review 2.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 3.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

4.  Chronic kidney disease and albuminuria in children with sickle cell disease.

Authors:  Marianne McPherson Yee; Shameem F Jabbar; Ifeyinwa Osunkwo; Lisa Clement; Peter A Lane; James R Eckman; Antonio Guasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

Review 5.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

6.  Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.

Authors:  Ashley Thrower; Emily J Ciccone; Poulami Maitra; Vimal K Derebail; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2018-11-21       Impact factor: 6.998

7.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

8.  Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.

Authors:  Sri L H Yeruva; Yonette Paul; Patricia Oneal; Mehdi Nouraie
Journal:  Hemoglobin       Date:  2016-09-18       Impact factor: 0.849

9.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

Review 10.  Sickle cell disease and the kidney.

Authors:  Jon I Scheinman
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.